Yemaachi Furthers African Cancer Research Agenda With New Breast Cancer Mutation, Research Networks
Yemaachi Biotech is preparing to expand a whole-exome sequencing pilot study, while pushing forward several other pan-African cancer research initiatives.
Liquid Biopsy – The necessary first step towards democratising precision oncology?
While IHC and imaging are useful for diagnosing and staging cancers, they are limited in their ability to inform clinical decision-making regarding the use of increasingly available targeted therapies that are revolutionising cancer care in developed countries. For this, more advanced molecular tests are required, and next generation sequencing-based liquid biopsy tests are at the cutting edge.
African biotech holds the key to transforming not just the health of African people, but our economies as well
Why has over a decade of political rhetoric and unprecedented donor support for scientific capacity building not translated into more tangible scientific output?
A closer look reveals a glaring gap in the current structure of the scientific ecosystem in Africa – the almost complete absence of the private sector.
Ghana startup strives for greater African representation in cancer research
As one of Ghana’s only labs equipped for molecular analysis, Bediako’s team have tasked themselves with collecting data they believe will advance the development of medicine for cancer patients throughout the continent and diaspora
Yemaachi Launches HPV Molecular Test in Ghana for At-Home Cervical Cancer Risk Assessment
GenomeWeb covers Yemaachi’s launch of its Sheba HPV Test, a convenient discreet way for women to screen themselves for HPV and assess their risk for cervical cancer.
Yemaachi Launches Sheba HPV Test for screening of high risk HPV variants that cause cervical cancer
Yemaachi marks cervical cancer awareness month with the launch of the Sheba HPV Test, a cervical cancer screening tool that features at-home sampling and high risk HPV DNA detection.